Discovering the Future of Pregnancy: Sera Prognostics to Unveil Prime Study Findings at 2025 SMFM Conference
The Impact of Sera Prognostics, Inc. PRIME Study on Maternal and Neonatal Health A Breakthrough in Pregnancy Biomarker Information It was a momentous day for Sera Prognostics, Inc., The Pregnancy Company®, as they announced that the results of the PRIME study had been accepted for oral podium presentation at the Society for Maternal-Fetal Medicine 2025…